keyword
https://read.qxmd.com/read/38624228/genomic-characterization-of-st38-ndm-5-producing-escherichia-coli-isolates-from-an-outbreak-in-the-czech-republic
#21
JOURNAL ARTICLE
Katerina Chudejova, Tsolaire Sourenian, Jana Palkovicova, Katarina Stredanska, Lucie Nechutna, Katerina Vlkova, Vendula Studentova, Jaroslav Hrabak, Costas C Papagiannitsis, Monika Dolejska, Ibrahim Bitar
A 2-year national genomic screening in the Czech Republic identified a notable prevalence of the New Delhi metallo-β-lactamase 5 (NDM-5)-producing Escherichia coli sequence type 38 (ST38) in the city of Brno. Forty-two ST38 E. coli isolates harbored the bla NDM-5 gene on the chromosome. Virulence factors confirmed the persistence of these isolates through biofilm formation. Single Nucleotide Polymorphisms (SNPs)-based phylogeny and CRISPR assay typing showed minimal genomic variations, implying a clonally driven outbreak...
April 16, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38624217/precise-genome-editing-underlines-the-distinct-contributions-of-mutations-in-erg11-erg3-mrr1-and-tac1-genes-to-antifungal-resistance-in-candida-parapsilosis
#22
JOURNAL ARTICLE
Sophie Hartuis, Isabelle Ourliac-Garnier, Estelle Robert, Marjorie Albassier, Léa Duchesne, Clara Beaufils, Joséphine Kuhn, Patrice Le Pape, Florent Morio
Candida parapsilosis has recently emerged as a major threat due to the worldwide emergence of fluconazole-resistant strains causing clonal outbreaks in hospitals and poses a therapeutic challenge due to the limited antifungal armamentarium. Here, we used precise genome editing using CRISPR-Cas9 to gain further insights into the contribution of mutations in ERG11 , ERG3 , MRR1 , and TAC1 genes and the influence of allelic dosage to antifungal resistance in C. parapsilosis . Seven of the most common amino acid substitutions previously reported in fluconazole-resistant clinical isolates (including Y132F in ERG11 ) were engineered in two fluconazole-susceptible C...
April 16, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38623982/evolution-of-prime-editing-systems-move-forward-to-the-treatment-of-hereditary-diseases
#23
JOURNAL ARTICLE
Olga V Volodina, Anastasia R Fabrichnikova, Arina A Anuchina, Olesya S Mishina, Alexander V Lavrov, Svetlana A Smirnikhina
The development of gene therapy using genome editing tools recently became relevant. With the invention of programmable nucleases, it became possible to treat hereditary diseases due to introducing targeted double strand break in the genome followed by homology directed repair (HDR) or non-homologous end-joining (NHEJ) reparation. CRISPR-Cas9 is more efficient and easier to use in comparison with other programmable nucleases. To improve the efficiency and safety of this gene editing tool, various modifications CRISPR-Cas9 basis were created in recent years, such as prime editing - in this system, Cas9 nickase is fused with reverse transcriptase and guide RNA, which contains a desired correction...
April 15, 2024: Current Gene Therapy
https://read.qxmd.com/read/38623252/correlation-between-ngs-panel-based-mutation-results-and-clinical-information-in-colorectal-cancer-patients
#24
JOURNAL ARTICLE
Bo Cheng, Lin Xu, Yunzhi Zhang, Huimin Yang, Shan Liu, Shanshan Ding, Huan Zhao, Yi Sui, Chan Wang, Lanju Quan, Jinhong Liu, Ye Liu, Hongming Wang, Zhaoqing Zheng, Xizhao Wu, Jing Guo, Zhaohong Wen, Ruya Zhang, Fei Wang, Hongmei Liu, Suozhu Sun
Early mutation identification guides patients with colorectal cancer (CRC) toward targeted therapies. In the present study, 414 patients with CRC were enrolled, and amplicon-based targeted next-generation sequencing (NGS) was then performed to detect genomic alterations within the 73 cancer-related genes in the OncoAim panel. The overall mutation rate was 91.5 % (379/414). Gene mutations were detected in 38/73 genes tested. The most frequently mutated genes were TP53 (60.9 %), KRAS (46.6 %), APC (30.4 %), PIK3CA (15...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38623240/using-machine-learning-methods-to-study-the-tumour-microenvironment-and-its-biomarkers-in-osteosarcoma-metastasis
#25
JOURNAL ARTICLE
Guangyuan Liu, Shaochun Wang, Jinhui Liu, Jiangli Zhang, Xiqing Pan, Xiao Fan, Tingting Shao, Yi Sun
BACKGROUND: The long-term prognosis for patients with osteosarcoma (OS) metastasis remains unfavourable, highlighting the urgent need for research that explores potential biomarkers using innovative methodologies. METHODS: This study explored potential biomarkers for OS metastasis by analysing data from the Cancer Genome Atlas Program (TCGA) and Gene Expression Omnibus (GEO) databases. The synthetic minority oversampling technique (SMOTE) was employed to tackle class imbalances, while genes were selected using four feature selection algorithms (Monte Carlo feature selection [MCFS], Borota, minimum-redundancy maximum-relevance [mRMR], and light gradient-boosting machine [LightGBM]) based on the gene expression matrix...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38621922/porcine-derived-pancreatic-enzyme-replacement-therapy-may-be-linked-to-chronic-hepatitis-e-virus-infection-in-cystic-fibrosis-lung-transplant-recipients
#26
JOURNAL ARTICLE
Christina S Thornton, Barbara J Waddell, Stephen E Congly, Julianna Svishchuk, Ranjani Somayaji, Linda Fatovich, Debra Isaac, Karen Doucette, Kevin Fonseca, Steven J Drews, Jamie Borlang, Carla Osiowy, Michael D Parkins
OBJECTIVES: In high-income countries hepatitis E virus (HEV) is an uncommonly diagnosed porcine-derived zoonoses. After identifying disproportionate chronic HEV infections in persons with cystic fibrosis (pwCF) postlung transplant, we sought to understand its epidemiology and potential drivers. DESIGN: All pwCF post-transplant attending our regional CF centre were screened for HEV. HEV prevalence was compared against non-transplanted pwCF and with all persons screened for suspected HEV infection from 2016 to 2022 in Alberta, Canada...
April 15, 2024: Gut
https://read.qxmd.com/read/38621192/genomic-considerations-in-the-treatment-of-thyroid-carcinoma
#27
EDITORIAL
Crystal J Hattum, Rachel J Elsey, Tobias Meissner, William C Spanos
Highlighting genomically driven targeted therapies to improve outcomes in advanced thyroid carcinoma.
April 15, 2024: JCO oncology practice
https://read.qxmd.com/read/38621176/first-isolation-of-japanese-encephalitis-virus-genotype-iv-from-mosquitoes-in-australia
#28
JOURNAL ARTICLE
Alyssa T Pyke, Peter Burtonclay, Nirdesh Poudel, Wayne Ingall, Neelima Nair, Sonja Hall-Mendelin, Scott B Craig, Craig Smith, Wei Wang, Jonathan M Darbro, Cassie C Jansen, Andrew F van den Hurk
Introduction: Widespread transmission of Japanese encephalitis virus (JEV) genotype four (GIV) occurred across mainland Australia in 2022. This resulted in forty-five human cases, including seven deaths, and the identification of JEV infection in over 80 commercial piggeries. Materials and Methods: We collected mosquitoes which were trapped using CO2 -baited light traps deployed near piggeries reporting disease or in regions linked to human cases in the Wide Bay region in the state of Queensland. Mosquitoes from four traps yielded JEV RNA by real-time RT-PCR...
April 15, 2024: Vector Borne and Zoonotic Diseases
https://read.qxmd.com/read/38621131/reversal-of-c9orf72-mutation-induced-transcriptional-dysregulation-and-pathology-in-cultured-human-neurons-by-allele-specific-excision
#29
JOURNAL ARTICLE
Aradhana Sachdev, Kamaljot Gill, Maria Sckaff, Alisha M Birk, Olubankole Aladesuyi Arogundade, Katherine A Brown, Runvir S Chouhan, Patrick Oliver Issagholian-Lewin, Esha Patel, Hannah L Watry, Mylinh T Bernardi, Kathleen C Keough, Yu-Chih Tsai, Alec Simon Tulloch Smith, Bruce R Conklin, Claire Dudley Clelland
Efforts to genetically reverse C9orf72 pathology have been hampered by our incomplete understanding of the regulation of this complex locus. We generated five different genomic excisions at the C9orf72 locus in a patient-derived induced pluripotent stem cell (iPSC) line and a non-diseased wild-type (WT) line (11 total isogenic lines), and examined gene expression and pathological hallmarks of C9 frontotemporal dementia/amyotrophic lateral sclerosis in motor neurons differentiated from these lines. Comparing the excisions in these isogenic series removed the confounding effects of different genomic backgrounds and allowed us to probe the effects of specific genomic changes...
April 23, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38619804/vascular-endothelial-growth-factor-and-ischemic-stroke-risk-a-mendelian-randomization-study
#30
JOURNAL ARTICLE
Xiao Zhang, Xinzhi Hu, Shiyuan Fang, Jiayao Li, Zhichao Liu, Weidun Xie, Ran Xu, Adam A Dmytriw, Kun Yang, Yan Ma, Liqun Jiao, Tao Wang
INTRODUCTION: Previous studies have reported controversial relationships between circulating vascular endothelial growth factors (VEGF) and ischemic stroke (IS). This study aims to demonstrate the causal effect between VEGF and IS using Mendelian randomization (MR). METHODS: Summary statistics data from two large-scale genome-wide association studies (GWAS) for 16,112 patients with measured VEGF levels and 40,585 patients with IS were downloaded from public databases and included in this study...
April 15, 2024: Neurology and Therapy
https://read.qxmd.com/read/38619743/a-multistep-in-silico-approach-identifies-potential-glioblastoma-drug-candidates-via-inclusive-molecular-targeting-of-glioblastoma-stem-cells
#31
JOURNAL ARTICLE
Nilambra Dogra, Parminder Singh, Ashok Kumar
Glioblastoma (GBM) is the highest grade of glioma for which no effective therapy is currently available. Despite extensive research in diagnosis and therapy, there has been no significant improvement in GBM outcomes, with a median overall survival continuing at a dismal 15-18 months. In recent times, glioblastoma stem cells (GSCs) have been identified as crucial drivers of treatment resistance and tumor recurrence, and GBM therapies targeting GSCs are expected to improve patient outcomes. We used a multistep in silico screening strategy to identify repurposed candidate drugs against selected therapeutic molecular targets in GBM with potential to concomitantly target GSCs...
April 15, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38619682/novel-pikfyve-tubulin-dual-target-inhibitor-as-a-promising-therapeutic-strategy-for-b-cell-acute-lymphoblastic-leukemia
#32
JOURNAL ARTICLE
Zhen Lu, Qian Lai, Zhi-Feng Li, Meng-Ya Zhong, Yue-Long Jiang, Li-Ying Feng, Jie Zha, Jing-Wei Yao, Yin Li, Xian-Ming Deng, Bing Xu
OBJECTIVE: In B-cell acute lymphoblastic leukemia (B-ALL), current intensive chemotherapies for adult patients fail to achieve durable responses in more than 50% of cases, underscoring the urgent need for new therapeutic regimens for this patient population. The present study aimed to determine whether HZX-02-059, a novel dual-target inhibitor targeting both phosphatidylinositol-3-phosphate 5-kinase (PIKfyve) and tubulin, is lethal to B-ALL cells and is a potential therapeutic for B-ALL patients...
April 15, 2024: Current Medical Science
https://read.qxmd.com/read/38619620/integrating-bulk-and-single-cell-sequencing-data-to-construct-a-scissor-dendritic-cells-prognostic-model-for-predicting-prognosis-and-immune-responses-in-escc
#33
JOURNAL ARTICLE
Maosheng Cheng, Jianqi Xiong, Qianwen Liu, Caihua Zhang, Kang Li, Xinyuan Wang, Shuang Chen
Esophageal squamous cell carcinoma (ESCC) is characterized by molecular heterogeneity with various immune cell infiltration patterns, which have been associated with therapeutic sensitivity and resistance. In particular, dendritic cells (DCs) are recently discovered to be associated with prognosis and survival in cancer. However, how DCs differ among ESCC patients has not been fully comprehended. Recently, the advance of single-cell RNA sequencing (scRNA-seq) enables us to profile the cell types, states, and lineages in the heterogeneous ESCC tissues...
April 15, 2024: Cancer Immunology, Immunotherapy: CII
https://read.qxmd.com/read/38619582/-molecular-pathological-analysis-through-the-ages
#34
REVIEW
Maria Walker, Eva-Maria Mayr, Mai-Lan Koppermann, Ana Terron, Yoko Wagner, Charlotte Kling, Nicole Pfarr
BACKGROUND: Molecular pathological examinations of tumor samples encompass a wide range of diagnostic analyses. Especially in recent years, numerous new biomarkers have come to the forefront-the analysis of which is crucial for therapy decisions. OBJECTIVES: Within the field of molecular pathology, the demands of next generation sequencing (NGS)-based requirements have experienced massive growth in recent years. To meet this demand, methods are constantly being adapted and further developed...
April 15, 2024: Pathologie (Heidelb)
https://read.qxmd.com/read/38619476/b-cell-receptor-signaling-proteins-as-biomarkers-for-progression-of-cll-requiring-first-line-therapy
#35
REVIEW
Mischa Y L Vervoordeldonk, Paul J Hengeveld, Mark-David Levin, Anton W Langerak
The molecular landscape of chronic lymphocytic leukemia (CLL) has been extensively characterized, and various potent prognostic biomarkers were discovered. The genetic composition of the B-cell receptor (BCR) immunoglobulin (IG) was shown to be especially powerful for discerning indolent from aggressive disease at diagnosis. Classification based on the IG heavy chain variable gene (IGHV) somatic hypermutation status is routinely applied. Additionally, BCR IGH stereotypy has been implicated to improve risk stratification, through characterization of subsets with consistent clinical profiles...
April 15, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38619278/mutation-patterns-predict-drug-sensitivity-in-acute-myeloid-leukemia
#36
JOURNAL ARTICLE
Guangrong Qin, Jin Dai, Sylvia Chien, Timothy J Martins, Brenda Loera, Quy H Nguyen, Melanie L Oakes, Bahar Tercan, Boris Aguilar, Lauren Hagen, Jeannine McCune, Richard Gelinas, Raymond J Monnat, Ilya Shmulevich, Pamela S Becker
PURPOSE: The inherent genetic heterogeneity of acute myeloid leukemia (AML) has challenged the development of precise and effective therapies. The objective of this study was to elucidate the genomic basis of drug resistance or sensitivity, identify signatures for drug response prediction, and provide resources to the research community. EXPERIMENTAL DESIGN: We performed targeted sequencing, high-throughput drug screening, and single-cell genomic profiling on leukemia cell samples derived from patients with AML...
April 15, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38619077/recommendations-for-the-management-of-initial-and-refractory-pediatric-status-dystonicus
#37
REVIEW
Lindsey M Vogt, Kathryn Yang, Gabriel Tse, Vicente Quiroz, Zainab Zaman, Laura Wang, Rasha Srouji, Amy Tam, Elicia Estrella, Shannon Manzi, Alfonso Fasano, Weston T Northam, Scellig Stone, Mahendranath Moharir, Hernan Gonorazky, Brian McAlvin, Monica Kleinman, Kerri L LaRovere, Carolina Gorodetsky, Darius Ebrahimi-Fakhari
Status dystonicus is the most severe form of dystonia with life-threatening complications if not treated promptly. We present consensus recommendations for the initial management of acutely worsening dystonia (including pre-status dystonicus and status dystonicus), as well as refractory status dystonicus in children. This guideline provides a stepwise approach to assessment, triage, interdisciplinary treatment, and monitoring of status dystonicus. The clinical pathways aim to: (1) facilitate timely recognition/triage of worsening dystonia, (2) standardize supportive and dystonia-directed therapies, (3) provide structure for interdisciplinary cooperation, (4) integrate advances in genomics and neuromodulation, (5) enable multicenter quality improvement and research, and (6) improve outcomes...
April 15, 2024: Movement Disorders: Official Journal of the Movement Disorder Society
https://read.qxmd.com/read/38618889/an-update-on-the-development-on-tubulin-inhibitors-for-the-treatment-of-solid-tumors
#38
REVIEW
Prasanna Anjaneyulu Yakkalaa, Shaik Rahaman, P S Lakshmi Soukya, Sajeli Ahil Begum, A Kamal
INTRODUCTION: Microtubules play a vital role in cancer therapeutics. They are implicated in tumorigenesis, thus inhibiting tubulin polymerization in cancer cells, and have now become a significant target for anticancer drug development. A plethora of drug molecules has been crafted to influence microtubule dynamics and presently, numerous tubulin inhibitors are being investigated. This review discusses the recently developed inhibitors including natural products, and also examines the preclinical and clinical data of some potential molecules...
April 15, 2024: Expert Opinion on Therapeutic Targets
https://read.qxmd.com/read/38618694/constructing-and-validating-a-risk-model-based-on-neutrophil-related-genes-for-evaluating-prognosis-and-guiding-immunotherapy-in-colon-cancer
#39
REVIEW
Shasha Wang, Lili Wang, Mingxiu Qiu, Zhongkun Lin, Weiwei Qi, Jing Lv, Yan Wang, Yangyang Lu, Xiaoxuan Li, Wenzhi Chen, Wensheng Qiu
BACKGROUND: Colon cancer is one of the most common digestive tract malignancies. Although immunotherapy has brought new hope to colon cancer patients, there is still a large proportion of patients who do not benefit from immunotherapy. Studies have shown that neutrophils can interact with immune cells and immune factors to affect the prognosis of patients. METHODS: We first determined the infiltration level of neutrophils in tumors using the CIBERSORT algorithm and identified key genes in the final risk model by Spearman correlation analysis and subsequent Cox analysis...
April 2024: Journal of Gene Medicine
https://read.qxmd.com/read/38618280/unveiling-the-mechanism-of-the-chaishao-shugan-formula-against-triple-negative-breast-cancer
#40
JOURNAL ARTICLE
Teng Fan, Yuanyuan Huang, Zeyu Liu, Jinsheng Huang, Bin Ke, Yuming Rong, Huijuan Qiu, Bei Zhang
BACKGROUND: The ChaiShao Shugan Formula (CSSGF) is a traditional Chinese medicine formula with recently identified therapeutic value in triple-negative breast cancer (TNBC). This study aimed to elucidate the underlying mechanism of CSSGF in TNBC treatment. METHODS: TNBC targets were analyzed using R and data were from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. The major ingredients and related protein targets of CSSGF were explored via the Traditional Chinese Medicine Systems Pharmacology database, and an ingredient-target network was constructed via Cytoscape to identify hub genes...
2024: Drug Design, Development and Therapy
keyword
keyword
33500
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.